LISBON, Portugal - July 2016: The Risk Assessment Report on α-PVP presents the data and findings of the risk assessment conducted by the extended Scientific Committee of the EMCDDA in November 2015. According to the report, α-PVP is used by recreational drug users as well as by problem drug users, including those who inject stimulants and opioids. The assessment findings show that a total of 116 deaths associated with the substance have been reported by eight Member States between 2012 and 2015. Presently, 21 EU Member States control α-PVP either under national drug legislation or other control measures.

For more information, please see:

http://www.emcdda.europa.eu/publications/risk-assessments/alpha-pvp